Literature DB >> 26277079

Body Mass Index as a Prognostic Factor in Resected Lung Cancer: Obesity or Underweight, Which Is the Risk Factor?

Takeshi Matsunaga1, Kenji Suzuki1, Kota Imashimizu1, Takamitsu Banno1, Kazuya Takamochi1, Shiaki Oh1.   

Abstract

BACKGROUND: In general, obesity is thought to be associated with increased surgical mortality and morbidity. On the other hand, low body mass index (BMI) has recently been reported as a poor prognostic factor for surgical candidates. This study investigated the effect of BMI on lung surgery.
METHODS: A retrospective study was conducted on 1,518 consecutive patients who had malignant pulmonary tumors resected between February 2008 and March 2013. BMI was used to classify patients according to the World Health Organization definition: BMI < 18.5: underweight (UW); BMI 18.5 to <25: normal weight (NW); BMI 25 to <30: overweight (OW); and BMI ≥ 30: obese (OB). We defined surgical resection-related mortality as any patient who died within 90 days after resection or while in the hospital. We analyzed morbidity and surgical resection-related mortality, and logistic regression analysis was used to identify predictors for surgical resection-related mortality.
RESULTS: Among the four groups, the incidence of cerebrovascular complications was 1.5% in UW, 0.4% in NW, 0% in OW, and 0% in OB, and that of pulmonary complications was 13.1% in UW, 8.4% in NW, 7.3% in OW, and 7.6% in OB. Surgical resection-related mortality was 2.9% in UW, 0.6% in NW, 1.7% in OW, and 0% in OB. Multivariate analysis revealed underweight, diffusing capacity of the lung for carbon monoxide, and male sex as the significant predictors.
CONCLUSIONS: In this study, low BMI was an independent risk factor for mortality, and the incidence of cerebrovascular and pulmonary complications tended to be higher in patients with low BMI than in obese patients. Underweight patients should be closely monitored following pulmonary resection. Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2015        PMID: 26277079     DOI: 10.1055/s-0035-1554964

Source DB:  PubMed          Journal:  Thorac Cardiovasc Surg        ISSN: 0171-6425            Impact factor:   1.827


  7 in total

1.  Determining the optimal number and location of cutoff points with application to data of cervical cancer.

Authors:  Chung Chang; Meng-Ke Hsieh; Wen-Yi Chang; An Jen Chiang; Jiabin Chen
Journal:  PLoS One       Date:  2017-04-27       Impact factor: 3.240

2.  Low Body Mass Index Is an Independent Predictive Factor after Surgical Resection in Patients with Non-Small Cell Lung Cancer

Authors:  Masaki Tomita; Takanori Ayabe; Kunihide Nakamura
Journal:  Asian Pac J Cancer Prev       Date:  2017-12-29

3.  Body Mass Index, Weight Loss, and Mortality Risk in Advanced-Stage Non-Small Cell Lung Cancer Patients: A Focus on EGFR Mutation.

Authors:  Yu-Mu Chen; Chien-Hao Lai; Chiung-Yu Lin; Yi-Hsuan Tsai; Ya-Chun Chang; Hung-Chen Chen; Chia-Cheng Tseng; Huang-Chih Chang; Kuo-Tung Huang; Yung-Che Chen; Wen-Feng Fang; Chin-Chou Wang; Tung-Ying Chao; Meng-Chih Lin
Journal:  Nutrients       Date:  2021-10-24       Impact factor: 5.717

4.  Obesity is associated with improved postoperative overall survival, independent of skeletal muscle mass in lung adenocarcinoma.

Authors:  Ji Hyun Lee; Young Cheol Yoon; Hyun Su Kim; Min Jae Cha; Jae-Hun Kim; Kyunga Kim; Hye Seung Kim
Journal:  J Cachexia Sarcopenia Muscle       Date:  2022-02-25       Impact factor: 12.910

5.  Risk factors for pulmonary complications after neoadjuvant chemoradiotherapy followed by surgery for non-small cell lung cancer.

Authors:  Ha Eun Kim; Woo Sik Yu; Chang Young Lee; Jin Gu Lee; Dae Joon Kim; Seong Yong Park
Journal:  Thorac Cancer       Date:  2021-12-14       Impact factor: 3.500

6.  Association of body mass index and outcomes following lobectomy for non-small-cell lung cancer.

Authors:  Cui Wang; Min Guo; Nan Zhang; Gongchao Wang
Journal:  World J Surg Oncol       Date:  2018-05-11       Impact factor: 2.754

Review 7.  Exploring the Impact of the Obesity Paradox on Lung Cancer and Other Malignancies.

Authors:  Lindsay Joyce Nitsche; Sarbajit Mukherjee; Kareena Cheruvu; Cathleen Krabak; Rohit Rachala; Kalyan Ratnakaram; Priyanka Sharma; Maddy Singh; Sai Yendamuri
Journal:  Cancers (Basel)       Date:  2022-03-11       Impact factor: 6.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.